Race could influence outcome after liver transplantation

January 24, 2002

N.B. Please note that if you are outside North America the embargo date for Lancet Press material is 0001 hours UK time Friday 25th January 2002.

Outcome after liver transplantation--both in terms of graft rejection and patients survival--could be related to race, with African American and Asian patients faring less well than white Americans and Hispanic patients, conclude authors of a study in this week's issue of THE LANCET.

Evidence from previous research suggests that long-term survival after kidney transplantation is substantially lower in African Americans than in other races. Paul Thuluvath and colleagues from Johns Hopkins University, Baltimore, USA, aimed to establish whether there was a difference in survival in African Americans compared with other races after liver transplantation, and whether race was an independent predictor of survival.

The investigators collected data from the United Network of Organ Sharing transplant registry for all liver transplants done between 1988 and 1996 in the USA. Information on age, sex, race, blood group, and cause of death for the donors and recipients was recorded.

The rate of graft failure due to chronic rejection was almost twice as high among African Americans compared to other races. Two-year graft survival was significantly lower for African Americans (601 of 884, 68%) and Asians (266 of 416, 64%) compared with white Americans (8703 of 11 762, 74%) and Hispanics (878 of 1220, 72%). Patients' two-year and five-year survival were significantly lower for African Americans (654 of 884 [74%], 270 of 565 [48%]) and Asians (287 of 416 [69%], 92 of 252 [37%]) compared with white Americans (9786 of 11 762 [83%], 4357 of 7514 [58%]) and Hispanics (964 of 1220 [79%], 341 of 657 [52%]). Race was an independent predictor of poor two-year survival, with African Americans and Asian patients having an increased risk profile of 36% and 25%, respectively, when compared with white Americans.

Paul Thuluvath comments: "Our study suggests that there is a clear need for prospective studies to examine our observations further. Until then, the reasons for poor survival in African Americans will remain speculative and will probably be dismissed as being due to poor compliance with therapy. Moreover, the higher rate of chronic rejection in African Americans suggests that there should be more rigorous drug trials in this patient population."
-end-
Contact: Dr Paul Thuluvath, Division of Gastroenterology, Johns Hopkins University, Room 429, 1830 Building 1830 E Monument Street, Baltimore MD 21205, USA; T) +1 410 614 5389; F) +1 410 614 9612; E) pjthuluv@welchlink.welch.jhu.edu

Lancet

Related Liver Transplantation Articles from Brightsurf:

Study reveals improving survival rates after liver transplantation in the UK
In the past two decades, death rates after liver transplantation have dropped by more than half in the UK, according to a recent analysis of almost 10,000 liver transplant recipients published in BJS (British Journal of Surgery).

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

US study reports dramatic reduction in likelihood of liver transplantation in patients with hepatoce
ILC 2018: Although hepatocellular carcinoma is now the leading indication for liver transplantation in the USA, the probability of patients receiving a transplant has declined significantly in recent years.

HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs
HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs.

Alcoholic liver disease replaces hepatitis C infection as the leading cause of liver transplantation in patients without hepatocellular carcinoma in the USA
Two independent US studies confirm that, from 2016 onwards, alcoholic liver disease has led to more liver transplants than hepatitis C infection in patients without hepatocellular carcinoma (HCC).

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Researchers develop new technique to model transplantation of the human liver
A novel technology developed by researchers at the Massachusetts General Hospital enables the model-ing of human liver transplantation in an experimental setting.

New method creates liver bioscaffolds with intact ECM for reseeding and transplantation
Researchers have reported a method for successfully removing the cellular material from whole human livers while retaining the organ's three-dimensional structure and extracellular matrix (ECM) components.

Routine hospital tool found to predict poor outcomes after liver transplantation
A routinely used hospital tool can predict which liver transplant recipients are more likely to do poorly after surgery, according to a study led by Cedars-Sinai.

Critically ill children can still undergo liver transplantation and survive
Advancements in critical care make it possible for even the sickest children to successfully undergo liver transplantation.

Read More: Liver Transplantation News and Liver Transplantation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.